Google Ad

ICMR comes out with checklist of antibody detection kits for use for sero-surveys – Home Health Choices

NEW DELHI: The Indian Council of Medical Research has launched a validated checklist of IgG ELISA kits for use for sero-surveys to know the proportion of inhabitants uncovered to COVID-19 together with asymptomatic people. The IgG ELISA kits are the primary indigenous antibody detection kits for coronavirus.

The apex well being analysis physique has to date authorized three batches of ‘COVID Kavach ELISA IgG kits’ developed by Zydus Cadila Healthcare Ltd, Ahmedabad, Gujarat.

Besides, one batch of Euroimmun Anti- SARS-COV-2 ELISA IgG manufactured by Euroimmun US Inc, USA, and a batch of Erbalisa COVID-19 IgG ELISA manufactured by Calbiotech Inc, USA have additionally been authorized.

The Indian Council of Medical Research (ICMR) additionally talked about the batch quantity, stating “responsibility for batch to batch consistency lies with the manufacturer”.

The IgG ELISA assessments are beneficial for sero-surveys to know the proportion of inhabitants uncovered to the infection, together with asymptomatic people.

“Depending upon the level of sero prevalence of infection, matching public health interventions can be implemented for prevention and control of the disease,” the analysis physique mentioned.

Further, it ought to be used for survey in high-risk or susceptible populations like healthcare staff, frontline staff, immune-compromised people, people in containment zones, to know who’ve been contaminated up to now and have now recovered.

The ICMR has additionally offered particulars of seven pharma firms to whom it has transferred the know-how to undertake the manufacturing of indigenous COVID Kavach ELISA IgG kits which assist in the antibody detection for COVID-19.

These check kits have the benefit of testing 90 samples in a single run of two.5 hours in order that healthcare professionals can proceed rapidly with vital subsequent steps.

“The ELISA tests have been validated in the laboratory. However, the performance of the test may be subject to variation under field conditions,” the ICMR added.

The IgG ELISA/CLIA assessments that are US-FDA authorized can be utilized immediately after due advertising approval from the Drugs Controller General of India (DCGI).

Latest Updates

Related Post